Peripheral blood myeloid-derived suppressor cells reflect disease status in IPF

I.E. Fernandez (Munich, Germany)

Source: ERS Lung Science Conference 2016
Number: 21

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I.E. Fernandez (Munich, Germany). Peripheral blood myeloid-derived suppressor cells reflect disease status in IPF. ERS Lung Science Conference 2016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LSC Abstract – Peripheral blood myeloid-derived suppressor cells reflect disease status in IPF
Source: International Congress 2016 – New therapies and therapeutic targets
Year: 2016

Peripheral blood myeloid-derived suppressor cells reflect disease status in idiopathic pulmonary fibrosis
Source: Eur Respir J 2016; 48: 1171-1183
Year: 2016



Peripheral blood Th17 and Th17/Th2 cells and their association with lung function and biomarkers in asthma-COPD overlap syndrome
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017

Myeloid-derived suppressor cells in the blood of COVID-19 patients
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021


Predicting prognosis of lung function decline in IPF using gene expression in peripheral blood mononuclear cells
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017


The emerging role of myeloid-derived suppressor cells in lung diseases
Source: Eur Respir J 2016; 47: 967-977
Year: 2016



Downregulation of mir-146a in peripheral blood mononuclear cells as a potential marker of NSCLC
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020

Levels of CD4CD25 T regulatory cells in bronchial mucosa and peripheral blood of chronic obstructive pulmonary disease indicate involvement of autoimmunity mechanisms
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019


Upregulation of myeloid derived suppressor cells (MDSCs) in chronic obstructive pulmonary disease and its relationship with disease severity
Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Year: 2012

Reciprocal imbalance or coexistence? The distribution of Th17 and Treg cells in peripheral blood lymphocytes in patients with non-small-cell lung cancer and its significance
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012

Diminished peripheral T cell activity in sarcoidosis associates with progressive disease.
Source: International Congress 2018 – Granulomatous disorders: epidemiology, genotype and phenotype
Year: 2018



Cytokine releasing mucosa-homing T cells are increased in peripheral blood of pulmonary fibrosis patients
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010


The complex role of SOCS1 expression in peripheral blood mononuclears of patients with bronchial asthma
Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease
Year: 2012

T-regulatory cells in COPD or tumour environment
Source: Eur Respir J 2009; 34: 284
Year: 2009


The fraction of circulating type 2 innate lymphoid cells in peripheral blood is associated with asthma severity
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019

Bronchial epithelial cells secrete an unknown factor that specifically activate inflammatory cytokine expression from neutrophils and peripheral blood mononuclear cells
Source: Annual Congress 2004 - Epithelial cells: critical regulation of pathogenic processes in disease
Year: 2004


Decreased numbers of human peripheral blood CD8+ve T-lymphocytes and the modification of their specific surface antigens in COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 309s
Year: 2002

Pulmonary dendritic cells from chronic obstructive pulmonary disease patients suppress lung immune responses through induction of regulatory T cells
Source: Annual Congress 2011 - T-cell subsets
Year: 2011

Characterisation of dendritic cells generated from peripheral blood monocytes of NSCLC patients
Source: Annual Congress 2007 - Biology of thoracic malignancies
Year: 2007


CD4+CD25+ T regulatory cells in the peripheral blood and BAL of lung transplanted patients
Source: Annual Congress 2004 - Bronchiolitis obliterans: new developments in investigating post-transplant airway disease
Year: 2004